ASLEUVAL

Name

ASLEUVAL

Legal name

Asociación de pacientes de leucemia, linfoma, mieloma y otras enfermedades de la sangre de la Comunidad Valenciana

Website

https://asleuval.org

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Non-Profit Patient Advocacy and Support Services

NAICS

Individual and Family Services (6241)

SIC

Services-Social Services (8300)

akta.pro industry

PRIMARYBPAGACAA

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

Keywords

• Patient advocacy association
• Oncohematological patient support
• Nonprofit healthcare services
• Cancer patient assistance
• Blood disease patient association

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Member contributions: Individuals become members (socios) by paying regular contributions (quarterly, semi-annual, or annual), providing recurring revenue to support ASLEUVAL's operations and services for oncohematological patients and their families.
2. Donations and grants: ASLEUVAL receives donations from individuals and institutional grants from public bodies (Generalitat Valenciana, Ayuntamiento de Valencia, Diputación de Valencia) and private entities (pharmaceutical companies, foundations) to fund its programs and activities.
3. Tax deduction incentives: As a declared entity of Public Utility (Utilidad Pública) under Law 49/2002, ASLEUVAL offers fiscal benefits to donors: individuals can deduct 80% of donations up to €250 (40-45% above that), and companies can deduct 40-50% of contributions, incentivizing charitable giving.

Distribution channels3 records

Marketing channels9 records

Core offering

ASLEUVAL is a non-profit patient association that delivers an integrated multi-disciplinary support ecosystem to oncohematological patients (leukemia, lymphoma, myeloma, and other blood diseases) and their families in the Valencian Community. Its core offering consists of direct patient services (social assistance, psychological support, physiotherapy, nutrition counseling, legal advice, oncology aesthetics, and a temporary accommodation facility), complemented by awareness campaigns, research grants (€15,000 per selected project), and annual educational events. The association is funded by member contributions, public grants, and corporate/philanthropic donations, with services delivered free of charge to beneficiaries.

Product overview

ASLEUVAL is a patient association offering a comprehensive support ecosystem for oncohematological patients (leukemia, lymphoma, myeloma, and other blood diseases) and their families in the Valencian Community. The organization provides direct patient services including social, psychological, physiotherapy, legal, and nutritional support, alongside a temporary accommodation facility for out-of-town patients. The association also conducts awareness campaigns, funds research projects through annual grants, and organizes educational events including the annual Foro Valenciano de Hematología, research-focused jornadas, and humanization conferences. All services are delivered through a WordPress-based website that also serves as the primary communication channel with members and the public.

Differentiator

Problem solved

Functional benefit

Products and services

• Atención Social Information and guidance on social benefits and available social resources based on the patient's socioeconomic situation; delivered to oncohematological patients and their families.
• Atención Psicológica Counseling and emotional support designed to reduce distress and improve adaptation to illness and treatment, delivered to oncohematological patients and their families.
• Atención Fisioterapéutica Physical prevention and intervention guidelines aimed at improving muscle mass and promoting independence for oncohematological patients.
• Piso de Acogida Temporary accommodation for patients and companions who, due to their pathology, need to stay near the healthcare center outside their usual residence; provided free of charge to beneficiaries.
• Voluntariado Voluntary action complementing the professional services of the association to support oncohematological patients and their families through companionship and assistance.
• Sensibilización y Difusión Awareness campaigns and dissemination about oncohematological diseases and the importance of donating blood, bone marrow, and umbilical cord blood.
• Asesoría Jurídica Guidance and legal advice on labor-law matters for oncohematological patients and their families.
• Nutrición Individualized nutritional counseling and guidance on food factors and dietary habits through personalized consultations for oncohematological patients.
• Estética Oncológica Oncological aesthetics services including guidance on headscarves for patients undergoing treatment.
• Programa de Acompañamiento Nutricional Especializado Specialized nutritional accompaniment program offering personalized consultations and educational workshops to improve nutritional status and treatment tolerance for oncohematological patients.
• Convocatoria de Proyectos Oncohematológicos Annual funding program for research and humanization projects in oncohematological diseases directed at public hospitals in the Valencian Community, awarding €15,000 per selected project.

Quantifiable outcome

• 148,767 patients and family members supported with resources aimed at improving quality of life

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

30 partnerships are on record, tiered core and minor.

• MICOF (Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia)coreStrategic or Co-development Partner · 18 June 2026MICOF is ASLEUVAL's key venue partner for the V Foro Valenciano de Hematología and collaborates on patient-focused events. Candela Almenar Monterde, Vocal de Relaciones Institucionales y Responsabilidad Social Corporativa del MICOF, participates in opening ceremonies. MICOF Xarxa Pacients also collaborates in jornadas.
• RochecoreGTM or Marketing PartnerRoche is a sponsor of the V Foro Valenciano de Hematología and IV Jornada de Investigación y Ciencia, contributing to ASLEUVAL's public education and awareness events. Also a sponsor of the January 2024 Humanización jornada.
• SanoficoreGTM or Marketing PartnerSanofi sponsors ASLEUVAL's flagship events including the V Foro Valenciano de Hematología, IV Jornada de Investigación y Ciencia, and is the driving force behind the EICR chronic jornada (organized by AEAL, impulsed by Sanofi). Contributes to patient education and research dissemination.
• AstraZenecacoreGTM or Marketing PartnerAstraZeneca sponsors ASLEUVAL's major hematology forums and events. Previously sponsored the I Foro Valenciano de Hematología. Active supporter of ASLEUVAL's science communication activities.
• GSKcoreGTM or Marketing PartnerGSK is a sponsor of the V Foro Valenciano de Hematología and IV Jornada de Investigación y Ciencia, contributing to the financing of ASLEUVAL's public education initiatives on hematological diseases.
• AbbviecoreGTM or Marketing PartnerAbbvie sponsors ASLEUVAL's major events including the V Foro Valenciano de Hematología and IV Jornada de Investigación y Ciencia, supporting the association's mission to inform and educate patients.
• Johnson & JohnsoncoreGTM or Marketing PartnerJohnson & Johnson co-sponsored the February 2026 Jornada sobre Humanización y Últimos Avances en Hematología, demonstrating a commitment to humanized healthcare in hematology alongside ASLEUVAL.
• Menarini StemlinecoreGTM or Marketing PartnerMenarini Stemline is a sponsor of ASLEUVAL's IV Jornada de Investigación y Ciencia and collaborator in hematology events. Also partnered on the February 2026 humanización jornada.
• PfizercoreGTM or Marketing PartnerPfizer sponsors the IV Jornada de Investigación y Ciencia and the February 2026 humanización jornada, supporting ASLEUVAL's science communication and patient education events.
• BeOnecoreGTM or Marketing PartnerBeOne (BGI) is listed as a collaborating establishment on ASLEUVAL's partners page and sponsors the IV Jornada de Investigación y Ciencia, supporting the association's research and science activities.
• Generalitat Valenciana /Conselleria de SanidadcoreStrategic or Co-development PartnerThe regional government body provides institutional support and collaboration on ASLEUVAL's hematology forums and jornadas. A representative of the Consellería de Sanidad participates in the opening sessions. ASLEUVAL also receives annual subsidies from this body for its interdisciplinary intervention programs (€14,991 in 2025, €16,099 in 2024).
• Ayuntamiento de ValenciacoreStrategic or Co-development PartnerThe Valencia city council is a collaborating establishment providing support to ASLEUVAL. In 2025, it granted a subsidy of €2,043.41 for citizen participation projects. Also supports the association's solidarity activities (e.g., San Silvestre run).
• Diputación de ValenciacoreStrategic or Co-development PartnerThe provincial council is a collaborator supporting ASLEUVAL through maintenance and development subsidies. Awarded €2,000 in 2025, €2,000 in 2024, €1,999 in 2023, and €1,999 in 2022 for local premises expenses.
• Fundación La CaixaminorStrategic or Co-development PartnerFundación La Caixa is listed as a collaborating establishment providing financial support to ASLEUVAL's community activities.
• Caixa PopularminorStrategic or Co-development PartnerCaixa Popular is listed as a collaborating establishment supporting ASLEUVAL's activities.
• Instituto de Investigación Sanitaria La FecoreStrategic or Co-development PartnerThe IIS La Fe is a key institutional collaborator hosting ASLEUVAL's IV Jornada de Investigación y Ciencia in its auditorium. Represents a center of excellence in hematology research and patient care in Valencia.
• Fundación Josep CarrerascoreStrategic or Co-development PartnerFundación Josep Carreras is listed as an affiliated entity and partner. ASLEUVAL links to REDMO (managed by the foundation) for bone marrow donor registration. Also collaborated on the EICR chronic study on quality of life.
• Sociedad Valenciana de Hematología y Hemoterapia (AVHH)coreStrategic or Co-development PartnerAVHH provides scientific and institutional endorsement (avales) for ASLEUVAL's events including the V Foro Valenciano de Hematología and IV Jornada de Investigación y Ciencia, and co-badged the I Foro Valenciano de Hematología.
• Sociedad Valenciana de Farmacia Hospitalaria (SVFH)minorStrategic or Co-development PartnerSVFH provided scientific endorsement for the I Foro Valenciano de Hematología and the IV Jornada de Investigación y Ciencia.
• AEAL (Asociación Española de Afectados por Linfoma, Mieloma y Leucemia)coreStrategic or Co-development PartnerAEAL is a national-level affiliated association working on EICR chronic awareness. Organized a reflection jornada on chronic EICR patient care with ASLEUVAL participation, bringing together patients, healthcare professionals, and institutional representatives.
• Organización Nacional de Trasplantes (ONT)coreStrategic or Co-development PartnerONT is listed as an affiliated entity. ASLEUVAL promotes bone marrow donation and REDMO registration in alignment with ONT's national plan. ONT participated in the institutional roundtable at the EICR chronic jornada.
• Agrupación Española de Entidades de Lucha contra la Leucemia y Enfermedades de la Sangre (AELCLES)minorStrategic or Co-development PartnerAELCLES is a national umbrella organization of leukemia and blood disease patient associations, of which ASLEUVAL is a member, facilitating broader coordination and advocacy at the national level.
• Grupo Español de Pacientes con Cáncer (GEPAC)minorStrategic or Co-development PartnerGEPAC is an affiliated entity representing Spanish cancer patients and is part of ASLEUVAL's network of related organizations.
• Fundación Leucemia y LinfomaminorStrategic or Co-development PartnerListed as an affiliated entity in ASLEUVAL's network of related organizations.
• Fundación MÁS QUE IDEASminorStrategic or Co-development PartnerListed as an affiliated entity in ASLEUVAL's network of related organizations.
• Clínica IlzarbeminorOthersA dental clinic with which ASLEUVAL has a formal agreement (convenio dental) offering preferential rates on dental services for ASLEUVAL members, direct family members, and employees.
• BCC ElevapracticminorOthersListed as a collaborating establishment providing support services to ASLEUVAL and its members.
• Fundación LealtadcoreOthersFundación Lealtad awarded ASLEUVAL its 'Dona con Confianza' (Donate with Confidence) seal and transparency accreditation, representing a quality certification that enhances donor trust and public credibility.
• Red Española de Universidades Promotoras de Salud (REUPS)minorStrategic or Co-development PartnerASLEUVAL participates in REUPS campaigns promoting blood and bone marrow donation across 32 Spanish universities, contributing to awareness and donor recruitment in the academic community.
• Fundación Internacional Josep Carreras (FIJC)coreStrategic or Co-development PartnerFIJC produced and published the 'Manual práctico sobre la Enfermedad Injerto contra Receptor' (EICR Practical Manual) for patients and caregivers, which ASLEUVAL distributes to its community. Also drove the EICR chronic quality-of-life study presented at ASLEUVAL-partnered jornadas.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• AELCLES (Agrupación Española de Entidades de Lucha contra la Leucemia y Enfermedades de la Sangre): National umbrella of Spanish blood disease patient associations of which ASLEUVAL is a member — directly comparable patient-advocacy constituency but acts as the convening coalition above individual associations like ASLEUVAL.
• GEPAC (Grupo Español de Pacientes con Cáncer): National umbrella of Spanish cancer patient associations. Listed as an affiliated entity of ASLEUVAL and operates the broader coalition ASLEUVAL participates in — comparable patient-advocacy mission at greater scale across all cancer types.
• Asociación Española Contra el Cáncer (AECC): Spain's largest cancer patient organization with national reach across all tumor types. Overlaps with ASLEUVAL in hematology patient support but operates at much greater scale across all cancers, making it a broad incumbent rather than direct peer.

Others

• Fundación Lealtad: Spanish NGO accreditation body that awarded ASLEUVAL its 'Dona con Confianza' transparency seal — comparable as the ecosystem enabler that certifies and benchmarks Spanish nonprofits of ASLEUVAL's size and category.

Direct peers

• Fundación Leucemia y Linfoma: Patient-focused foundation dedicated to leukemia and lymphoma support and research — directly comparable disease scope to ASLEUVAL, listed as an affiliated entity in ASLEUVAL's network.
• Fundación Josep Carreras contra la Leucemia: Spain's leading leukemia-focused foundation operating the REDMO bone marrow donor registry — directly comparable to ASLEUVAL in disease focus and a current institutional partner via REDMO referrals and EICR manual collaboration.
• Fundación MÁS QUE IDEAS: Spanish patient-focused foundation addressing hematological and oncological patient quality-of-life needs — comparable mission to ASLEUVAL across psychosocial support, and listed as an affiliated organization in ASLEUVAL's network.
• AEAL (Asociación Española de Afectados por Linfoma, Mieloma y Leucemia): National Spanish patient association for lymphoma, myeloma, and leukemia — the direct national counterpart to ASLEUVAL's disease focus, covering the same oncohematological patient population at country scope. ASLEUVAL already collaborates with AEAL on EICR chronic programming.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/asleuval_valencia
• YouTubeyoutube.com/@asleuval
• Facebookfacebook.com/asleuval
• Instagraminstagram.com/asleuval_valencia
• TikToktiktok.com/@asleuval
• LinkedInlinkedin.com/company/asleuval

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASLEUVAL